Share on LinkedInShare on LinkedIn

ARTICLE · 06 APRIL 2021

Covid-19 Key EU Developments Policy & Regulatory Update No. 40

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

European UnionCoronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing
  • European Parliament issues Study on Non-performing Loans ("NPLs"), including addressing EU State aid rules and potential surge in NPLs due to COVID-19 crisis
  • EU approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Commission extends export authorization mechanism for COVID-19 vaccines until 30 June 2021

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from